Redeye reiterates its positive view of Speqta, after a quarter with revenues that were in line with our estimates but with considerably stronger margins, primarily in the C&C segment. Although the pandemic is currently causing challenges, we deem these temporary and expect Speqta to be a clear post-Covid-19 winner. Moreover, Bidbrain is set to be launched in Q2, and the combination should put Speqta back on its strong growth path.